Your browser doesn't support javascript.
loading
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi, Alice; Quaglino, Pietro; Rubatto, Marco; Depenni, Roberta; Guida, Michele; Ascierto, Paolo Antonio; Trojaniello, Claudia; Queirolo, Paola; Saponara, Maristella; Peris, Ketty; Spagnolo, Francesco; Bianchi, Luca; De Galitiis, Federica; Potenza, Maria Concetta; Proietti, Ilaria; Marconcini, Riccardo; Botticelli, Andrea; Barbieri, Vito; Licitra, Lisa; Alfieri, Salvatore; Ficorella, Corrado; Cortellini, Alessio; Fargnoli, Maria Concetta; Troiani, Teresa; Tondulli, Luca; Bossi, Paolo.
Affiliation
  • Baggi A; University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, Italy.
  • Quaglino P; University of Turin, Dermatologic Clinic, Department of Medical Sciences Torino, Piemonte, Italy.
  • Rubatto M; University of Turin, Dermatologic Clinic, Department of Medical Sciences Torino, Piemonte, Italy.
  • Depenni R; Università degli Studi di Modena e Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy.
  • Guida M; IRCCS Istituto Oncologico di Bari Giovanni Paolo II, Oncology Department, Bari, Puglia, Italy.
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy.
  • Trojaniello C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy.
  • Queirolo P; IEO, Division of Medical Oncology for Melanoma, Sarcoma and Rare Tumors, Milano, Lombardia, Italy.
  • Saponara M; IEO, Division of Medical Oncology for Melanoma, Sarcoma and Rare Tumors, Milano, Lombardia, Italy.
  • Peris K; Università Cattolica del Sacro Cuore Campus di Roma, Istitute of Dermatology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy.
  • Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Liguria, Italy.
  • Bianchi L; University of Rome Tor Vergata, Dermatologic Unit, Department of Systems Medicine, Roma, Lazio, Italy.
  • De Galitiis F; Istituto Dermopatico dell'Immacolata IRCCS, Roma, Lazio, Italy.
  • Potenza MC; Sapienza University of Rome, Dermatology Unit "Daniele Innocenzi", Department of Medical-Surgical Sciences and Biotechnologies Polo Pontino, Terracina, Italy.
  • Proietti I; Sapienza University of Rome, Dermatology Unit "Daniele Innocenzi", Department of Medical-Surgical Sciences and Biotechnologies Polo Pontino, Terracina, Italy.
  • Marconcini R; Azienda Ospedaliero Universitaria Pisana, Medical Oncology Unit, Pisa, Italy.
  • Botticelli A; Sapienza University of Rome, Clinical and Molecular Department, Umberto I Policlinico di Roma, Roma, Lazio, Italy.
  • Barbieri V; Azienda Ospedaliera di Catanzaro Pugliese Ciaccio, U.O. Oncologia, Catanzaro, Calabria, Italy.
  • Licitra L; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Cancer Medical Oncology 3 Department, University of Milan, Department of Hematology and Oncology, Milano, Lombardia, Italy.
  • Alfieri S; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Cancer Medical Oncology 3 Department, Milano, Lombardia, Italy.
  • Ficorella C; University of L'Aquila Department of Clinical Sciences and Applied Biotechnology, L'Aquila, Abruzzo, Italy; San Salvatore Hospital, Medical Oncology, L'Aquila, Abruzzo, Italy.
  • Cortellini A; University of L'Aquila Department of Clinical Sciences and Applied Biotechnology, L'Aquila, Abruzzo, Italy; Imperial College London, Department of Surgery and Cancer, London, UK.
  • Fargnoli MC; University of L'Aquila Department of Clinical Sciences and Applied Biotechnology, L'Aquila, Abruzzo, Italy; San Salvatore Hospital, Medical Oncology, L'Aquila, Abruzzo, Italy.
  • Troiani T; University of Campania Luigi Vanvitelli, Medical Oncology, Department of Precision Medicine, Napoli, Campania, Italy.
  • Tondulli L; Integrated University Hospital of Verona, Oncology Department, University Hospital of Verona, Verona, Veneto, Italy.
  • Bossi P; University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, Italy. Electronic address: paolo.bossi@unibs.it.
Eur J Cancer ; 157: 250-258, 2021 11.
Article in En | MEDLINE | ID: mdl-34536948
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Drug-Related Side Effects and Adverse Reactions / Antibodies, Monoclonal, Humanized / Immune Checkpoint Inhibitors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Drug-Related Side Effects and Adverse Reactions / Antibodies, Monoclonal, Humanized / Immune Checkpoint Inhibitors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Affiliation country: